<scp>Real‐world</scp> effectiveness and safety of insulin glargine 300 <scp>U/ml</scp> in <scp>insulin‐naïve</scp> people with type 2 diabetes in the <scp>Latin America</scp> region: A subgroup analysis of the <scp>ATOS</scp>-Reference-Cited by-同舟云学术

Real‐world effectiveness and safety of insulin glargine 300 U/ml in insulin‐naïve people with type 2 diabetes in the Latin America region: A subgroup analysis of the ATOS

Published:2022-10-09 Issue:1 Volume:25 Page:238-247
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Vargas‐Uricoechea Hernando¹^ORCID,Burga Nuñez José Luis²,Rosas Guzmán Juan³,Silva‐Gomez Liliana⁴^ORCID,Beltran Sergio⁴,Sañudo‐Maury María Elena⁵^ORCID

Affiliation:

1. Division of Endocrinology and Metabolism, Department of Internal Medicine Universidad del Cauca Popayan Colombia

2. Centro de Investigación Arequipa – EXACTA LAB SAC Yanahuara Peru

3. Centro de Especialidades Médicas de Celaya Guanajuato Mexico

4. Medical Department Sanofi Bogotá Colombia

5. Medical Department Sanofi Mexico City Mexico

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14868